Viral Vector Development - Focus on Adeno-associated Virus, 2018 - 2021

Table of Contents

Chapter 1 Market Lineage
                  1.1 Parent Market Outlook
                  1.2 Ancillary Market Outlook
Chapter 2 Industry Dynamics
                  2.1 AAV Development Process
                  2.2 Viral Vector based gene therapy development
                  2.3 Pipeline for AAV
                  2.4 Funding for development
                  2.5 Current & Future production quality standards
Chapter 3 Viral Vector Deep dive for AAV & Lentivirus
                  3.1 Comparative analysis between AAV, LVV and other viral Vectors
                  3.2 Cell line type for current supply
                  3.3 Case study on setting up a development plant
                  3.4 Case study on cost of manufacturing (based on batch size)
Chapter 4 Competitive Analysis
                  4.1 AAV in clinical trials (with focus on sponsoring companies)
                  4.2 Bioreactors used for development
                  4.3 Strategic initiatives undertaken in last 5 years
Chapter 5 Observation & Recommendations